About CNS Therapy
CNS Therapy is a company based in Lindau (Germany) founded in 2014. CNS Therapy has raised $1.11 million across 3 funding rounds from investors including European Union and EIC Fund. CNS Therapy offers products and services including Systolic Extinction Training (SET) and AI Monitoring System. CNS Therapy operates in a competitive market with competitors including Regenesis, Thought Technology, PowerDot, Bluetens and ADM Tronics, among others.
- Headquarter Lindau, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Cns Therapy Ag
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.11 M (USD)
in 3 rounds
-
Latest Funding Round
$1.11 M (USD), Seed
Sep 20, 2023
-
Investors
European Union
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CNS Therapy
CNS Therapy offers a comprehensive portfolio of products and services, including Systolic Extinction Training (SET) and AI Monitoring System.
Combines therapy and device to reduce chronic pain non-invasively.
Tracks physiological data to optimize chronic pain treatments.
Funding Insights of CNS Therapy
CNS Therapy has successfully raised a total of $1.11M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $1.11 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CNS Therapy
CNS Therapy has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for CNS Therapy
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CNS Therapy
Investment portfolio details for CNS Therapy
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CNS Therapy
Detailed financials for CNS Therapy
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cns Therapy Comparisons
Peer comparison for CNS Therapy
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CNS Therapy
CNS Therapy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Regenesis, Thought Technology, PowerDot, Bluetens and ADM Tronics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
At-home non-drug pain relief devices are provided for patients.
|
|
| Locked | Locked | Locked |
Provides biofeedback hardware and software for psychological and physiological monitoring and training.
|
|
| Locked | Locked | Locked |
Mobile app-based electronic muscle stimulator for recovery is provided.
|
|
| Locked | Locked | Locked |
Offers electrostimulation devices and apps for pain relief, muscle recovery, and wellness.
|
|
| Locked | Locked | Locked |
Electronic medical devices and components are manufactured by ADM Tronics.
|
Detailed competitors of CNS Therapy
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cns Therapy
Complete news archive for CNS Therapy
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CNS Therapy
CNS Therapy was founded in 2014 and raised its 1st funding round 5 years after it was founded.
CNS Therapy is headquartered in Lindau, Germany. It is registered at Lindau, Bavaria, Germany.
Marc Mathys is the current CEO of CNS Therapy.
CNS Therapy is a funded company, having raised a total of $1.11M across 3 funding rounds to date.
CNS Therapy, spun-out of the University of North Carolina, is developing a device for chronic pain. The companys core technology is a patent pending solution to chronic pain which combines operant behavioral therapy with a proprietary device which enhances learning and resets the autonomic nervous system called SET Systolic Extinction Training. The company aims to provide long lasting pain relief to patients, with its combination of psychological training and electrostimulation.
CNS Therapy's top competitors include Regenesis, ADM Tronics and PowerDot.
CNS Therapy offers Systolic Extinction Training (SET) and AI Monitoring System.
CNS Therapy has 2 investors. Key investors include European Union, and EIC Fund.